A Randomized, Double-Blind Study to Evaluate the Effect of Various re-Treatment Regimens of MabThera in Combination With Methotrexate on Treatment Response in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate.
Phase of Trial: Phase III
Latest Information Update: 07 May 2015
At a glance
- Drugs Rituximab (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics; Registrational; Therapeutic Use
- Acronyms MIRROR
- Sponsors Roche
- 07 Jun 2017 Biomarkers information updated
- 25 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Sep 2012 Planned end date changed from 1 May 2014 to 1 Aug 2013 as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History